Navigation Links
Texas Biomed develops new approach to study depression; finding may lead to new marker for risk
Date:10/28/2011

Scientists at the Texas Biomedical Research Institute and Yale University have identified a new target area in the human genome that appears to harbor genes with a major role in the onset of depression.

Using the power of Texas Biomed's AT&T Genomics Computing Center (GCC), the researchers found the region by devising a new method for analyzing thousands of potential risk factors for this complex disease, a process that led them to a new biomarker that may be helpful in identifying people at risk for major depression.

"We were searching for things in psychiatric disease that are the equivalent of what cholesterol is to heart disease," said John Blangero, Ph.D., director of the GCC and a principal investigator in the study. "We wanted to find things that can be measured in everybody and that can tell you something about risk for major depression."

The study was directed by Blangero and David Glahn, Ph.D., of Yale University. It was published online in October in the journal Biological Psychiatry and supported by the National Institutes of Health.

Major depressive disorder is one of the most common and most costly mental illnesses. Studies have estimated that up to 17 percent of Americans will suffer depression at some point in their lives. The disorder has proven to be a tough challenge for geneticists. Despite strong evidence that people can inherit a susceptibility to major depression, years of study have failed to locate any of the key genes that underlie the illness. The scientists used blood samples from 1,122 people enrolled in the Genetics of Brain Structure and Function Study, a large family study that involves people from 40 extended Mexican American families in the San Antonio area.

Blangero and his colleagues looked at more than 11,000 endophenotypes, or heritable factors, and searched for the ones that were linked with the risk of major depression. They found that disease risk correlated most strongly with expression levels of a gene called RNF123, which helps regulate neuron growth.

Once they found this risk factor, further analysis directed scientists to an area on chromosome 4 containing genes that appear to regulate RNF123.

Because the RNF123 expression levels can be measured relatively easily in the blood, this finding could lead to a way of identifying people at risk for major depressive disorder, Blangero said.

"We might be able to know in advance that a person will be less able to respond to the normal challenges that come about in life," he said. "Then doctors may be able to intervene earlier after a traumatic life event to remove some of the debilitation of depression."

The study also shows the potential for using this method of analyzing a multitude of heritable traits as a way to zero in on disease-causing gene variants.

The research capitalized on the newest 'deep sequencing' technology that enables Texas Biomed scientists to search through more genetic variables. The GCC has 8,000 linked computer processors that are capable of analyzing millions of genetic variables drawn from thousands of research subjects.
'/>"/>

Contact: Joseph Carey
jcarey@txbiomed.org
210-158-9437
Texas Biomedical Research Institute
Source:Eurekalert

Related biology news :

1. Earth scientists keep an eye on Texas
2. 7 Texas mammals listed as threatened on Global Mammal Assessment
3. Texas A&M anthropologist discovers long-lost primate in Indonesia
4. Texas invests record $3.5 million in startup cofounded by UTs Mauro Ferrari
5. Texas College Police Unit Deploys BIO-key(R) Mobile Data System
6. UT Southwestern scientist honored among best in Texas research
7. Texas Medical Center researchers win collaborative grants
8. Famous fossil Lucy scanned at the University of Texas at Austin
9. Texas researchers provide emissions data for livestock industry
10. Texas Obesity Research Center at UH assembles researchers to discuss obesity
11. Texas-sized tract of single-celled clones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Lithuania, announced today that they have entered into a multiyear collaboration to identify ... CRISPR researchers with additional tools for gene editing across all applications. , Under ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
Breaking Biology Technology: